| Expression pattern: |
UP |
| Associated gene: |
RNF38, Ago2, GLUT1 |
| Associated microRNA: |
miR-377-3p |
| Biological function: |
Promotes HCC progression by promoting proliferation, migration, invasion, and glycolysis and inhibiting apoptosis; silencing inhibits tumor growth in vivo. |
| Molecular mechanism: |
Acts as a miRNA sponge (ceRNA) for miR-377-3p to increase RNF38 expression. |
| Biological pathway or process: |
proliferation (promotes); apoptosis (inhibits); migration (promotes); invasion (promotes); glycolysis (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); Transfection; MTT; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; In Vivo Animal Model |
| Clinical significance: |
High circ-CFH expression was associated with high TNM stage and metastasis; suggested as a predictor/diagnostic marker for HCC prognosis. |
| Description: |
circ-CFH is up-regulated in HCC tissues/cells and promotes malignant phenotypes (proliferation, migration, invasion, glycolysis) while inhibiting apoptosis. It functions mainly as a ceRNA sponge for miR-377-3p, thereby increasing RNF38 expression and accelerating HCC progression; circ-CFH silencing suppresses xenograft tumor growth. |
| Confidence score: |
0.7045 |